ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business OfficerROCKVILLE, MD / ACCESS Newswire / August 10, 2026 / ABL Inc and Ascend Advanced Therapies today announced the appointment of Suman Subramanian as Chief Business Officer (CBO), further strengthening the Company's commercial leadership and its commitment to supporting customers with the development and manufacturing of viral vectors, vaccines, biologics and advanced therapies.
EW Healthcare Partners Acquires Germfree Laboratories, Inc.Manufacturer positioned to deliver solutions to ease space constraints in the fast-growing cell and gene therapy sector
